发明名称 |
Combination comprising paroxetine and 2-(s)-(4-fluoro-2-methyl-phenyl) -piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide for treatment of depression and/or anxiety |
摘要 |
The present invention relates to therapeutic combinations comprising paroxetine or physiologically acceptable salts or solvates thereof and 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)]-(2S-phenyl-piperidin-3S-yl)-amine or physiologically acceptable salts or solvates thereof, to pharmaceutical compositions containing said combinations and their use in the treatment of depression and/or anxiety. |
申请公布号 |
ZA200508067(B) |
申请公布日期 |
2007.02.28 |
申请号 |
ZA20050008067 |
申请日期 |
2005.10.06 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
MELOTTO, SERGIO;CORSI, MAURO;CARLETTI, RENZO |
分类号 |
A61K;A61K31/445;A61K45/06;A61P;A61P25/00 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|